1 Department of Pediatrics, Division of Gastroenterology and Nutrition and 2 Department of Medicine, Division of Respirology, The University of Toronto, Toronto, Ontario, Canada M5S 1A8; 3 Department of Medicine, Division of Respirology, The University of Sherbrooke, Sherbrooke, Quebec, J1H 5N4; 4 Faculty of Dentistry, University of Toronto, CIHR Group in Periodontal Physiology and 5 Department of Pathobiology and Laboratory Medicine, The University of Toronto, Toronto, Ontario, Canada M5S 1A8
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Neutrophil-mediated injury to gut epithelium may lead
to disruption of the epithelial barrier function with consequent organ dysfunction, but the mechanisms of this are incompletely characterized. Because the epithelial apical junctional complex, comprised of tight
and adherens junctions, is responsible in part for this barrier
function, we investigated the effects of neutrophil transmigration on
these structures. Using a colonic epithelial cell line, we observed
that neutrophils migrating across cell monolayers formed clusters that
were associated with focal epithelial cell loss and the creation of
circular defects within the monolayer. The loss of epithelial cells was
partly attributable to neutrophil-derived proteases, likely elastase,
because it was prevented by elastase inhibitors. Spatially delimited
disruption of epithelial junctional complexes with focal loss of
E-cadherin, -catenin, and zonula occludens 1 was observed adjacent
to clusters of transmigrating neutrophils. During neutrophil
transmigration, fragments of E-cadherin were released into the apical
supernatant, and inhibitors of neutrophil elastase prevented this
proteolytic degradation. Addition of purified leukocyte elastase also
resulted in release of E-cadherin fragments, but only after opening of
tight junctions. Taken together, these data demonstrate that
neutrophil-derived proteases can mediate spatially delimited disruption
of epithelial apical junctions during transmigration. These processes
may contribute to epithelial loss and disruption of epithelial barrier
function in inflammatory diseases.
leukocyte; inflammation; adherens junctions; adhesion molecules; epithelium; inflammatory mediators; tight junctions
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
EPITHELIAL CELLS FORM A SELECTIVE barrier and are responsible for the active transport of fluid, ions, and small molecules. Epithelial injury can occur as a consequence of inflammation when injury to the epithelium of organs (e.g., intestine, kidney, and lung) is associated with extensive infiltration by neutrophils (4, 21, 41). In these disorders, unregulated movement of fluid and electrolytes across the injured epithelium can lead to edema of the organ (e.g., pulmonary edema) or loss of fluid and electrolytes from the body (e.g., diarrhea).
Polarized epithelial cells maintain their structural and
functional characteristics in part through their apical tight junctions and adherens junctions. Zonula occludens 1 (ZO-1) is part of the tight
junction cytoplasmic plaque that links occludin to the actin cytoskeleton (43). Epithelial adherens junctions are
comprised of a cytoskeletal domain, a plaque structure (e.g.,
-catenin), and integral membrane components (e.g., E-cadherin).
E-cadherin is a transmembrane protein important in calcium-dependent
epithelial cell-cell interactions (15).
Alterations in the epithelial junctional complex may be important in the pathogenesis of inflammatory diseases. Disruption of epithelial tight junctions may contribute to leakage of plasma proteins into the airway in asthma (26) and to abnormalities of fluid and electrolyte transport in renal failure (33). Furthermore, expression of a dominant negative cadherin mutant in the small intestine of mice resulted in histopathological features similar to those observed in Crohn's disease (22). It is noteworthy that junctional proteins may be passive targets of inflammatory processes as well as actively influence epithelial inflammatory injury and repair (22, 23).
In inflammatory diseases, leukocytes release cytotoxic compounds during emigration from the vascular space (reviewed in Ref. 25). Recent reports suggest that neutrophil transmigration across endothelium may disrupt adherens junctions by release of proteases (3, 10). However, these observations may be in part due to artifactual release of neutrophil proteolytic activity during cell permeabilization that is required for immunofluorescence staining (34).
Compared to endothelial transmigration, less is known about leukocyte transmigration across epithelium. In vitro systems suggest that epithelial cells actively facilitate neutrophilic polymorphonuclear leukocyte (PMN) transmigration in the physiological (basolateral to apical) direction (29, 42). A reversible decrease in transepithelial resistance during PMN transmigration may be due to physical disruption of the monolayer or from a PMN-derived secretagogue (37). Recent studies of PMN transmigration have described sites of microinjury in the epithelial monolayer (39). Subsequently, during the repair phase, epithelial cells extend actin-rich lamellipodia into these defects, initiating a process that leads to restitution of the integrity of the epithelial monolayer (39). However, the effects of PMN transmigration on the epithelial apical junctional complex are not known.
The purposes of the present study were 1) to characterize the effects of PMN transmigration on the epithelial adherens junction complex and 2) to determine the mechanism of these effects and their sequelae on epithelial function. The studies reported herein demonstrate that neutrophils migrate by moving primarily between epithelial cells, and this results in transient disruption of interepithelial junctions and later to focal loss of epithelial cells, creating circular defects within the monolayer (microinjury). The disruption of the interepithelial junctions and loss of epithelial cells is in part attributable to leukocyte-derived proteases. These studies provide novel insights into the mechanisms of inflammatory injury to epithelium and suggest potential targets for anti-inflammatory therapy.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture and monolayer treatments.
Human T84 cells (provided by Dr. P. Sherman, The Hospital for Sick
Children, Toronto) were grown in a 1:1 mix of DMEM and Ham's F-12
Nutrient Mix (GIBCO, Grand Island, NY) supplemented with 10% (vol/vol)
heat-inactivated fetal bovine serum (Cansera International, Rexdale,
Ontario) and 2% (vol/vol) penicillin-streptomycin (GIBCO/BRL) and
grown at 37°C in 5% CO2. T84 cells were either seeded
onto inverted polycarbonate filters (1-cm2 surface area,
3.0-µm pore, Costar, Cambridge, MA) or grown to confluence in 12-well
culture plates. After overnight incubation, filters were placed upright
in 12-well culture plates so that the epithelial side was on the lower
(dependent) side of the filter. When indicated, epithelial cells were
incubated with either 0.5 × 106 M
-1 antitrypsin
(Bayer, Toronto, Ontario, Canada, further purified as previously
described Ref. 6) for 45 min or EDTA (2 mM for 12 min) to
open tight junctions, followed by the addition of 1.5 U/ml of purified
leukocyte elastase (Sigma Chemical, St. Louis, MO) for 1 h.
Transepithelial resistance measurements. Transepithelial resistance was measured with a dual-voltage Ohmmeter clamp (World Precision Instruments, Sarasota, FL); readings in ohms were taken by using Ag/AgCl electrodes and were expressed as percentage of baseline. Inserts were used between days 5 and 10 after seeding, when transepithelial electrical resistance was greater than 800 ohms · cm2. Measurements were recorded at the start of each experiment and at indicated time intervals.
Neutrophil isolation and transmigration assay. Human PMN (>98% pure) were isolated from citrated whole blood by discontinuous plasma-Percoll gradients (20), resuspended in Hanks' balanced salt solution (HBSS; GIBCO/BRL) and used immediately after isolation. The integrity and nonactivated state of PMN isolated in this manner have been previously validated (12, 20). When indicated, PMN were pretreated with 1) 2.5 mM diisopropylphosphate (DFP), an inhibitor of serine proteases (Calbiochem-Novobiochem, La Jolla, CA) for 2-15 min incubation periods; 2) 12 µm Dupont Merck Pharmaceuticals (DMP)-777, a specific inhibitor of PMN elastase (gift from Dupont Pharmaceutical, Wilmington, DE) for 10 min; 3) 10 µM diphenylene iodonium (DPI, synthesized as previously described) (44) for 2 min; or 4) nitro-L-arginine methyl ester (L-NAME; Sigma Chemical) an inhibitor of nitric oxide synthase. PMN were added to the upper compartment of inserts; transmigration was induced by a chemotactic gradient established with a final concentration of 1 µM N-formylmethionyl-leucyl-phenylalanine (fMLP) in the lower compartment. All inserts were washed and incubated in HBSS for 45 min before the addition of PMN.
Morphometric analysis of the epithelial disruption. To quantify epithelial monolayer disruption after induced PMN transmigration, filters were fixed in formyl alcohol and stained with hematoxylin and eosin. The number of defects in the epithelial monolayer was measured at ×100 magnification along the diameter of the filter (1.0 cm), in a transect 1.25 mm wide, comprising 12.5% of the area of the filter. In each filter, the diameters of defects in the epithelium were measured at ×200 magnification; all defects in a vertical transect 0.5 mm in width extending from the periphery of the filter to the filter meridian were measured. If fewer than 20 defects were present in the transect, all defects in repeated transects were measured until the diameters of at least 20 defects in each filter were obtained. The surface area of epithelium lost in each filter was calculated from the diameter of the circular defects and from the density of the defects observed. Epithelial cell diameter was measured by transmitted light microscopy and was found to be 30 µm on average. The measurements were made by an investigator blinded to the treatment protocols of each filter.
Quantification of PMN transmigration. PMN transmigration was measured in two ways. 1) Labeling with calcein AM: PMN were incubated with 1.5 µM calcein AM for 20 min at 37°C and then washed twice. Cells were added to the top chamber of wells, and chemotaxis was induced for 2 h by addition of 1 µM fMLP to the bottom chamber. Fluorescence was measured in the bottom chamber on a fluorescent plate reader (Cytofluor 2300; Millipore, Bedford, MA). The number of cells transmigrated was determined by using standard linear curves of fluorescence vs. known number of PMN separately constructed for each experiment. The fluorescence assay was used for the quantification of all transmigration experiments except those involving the use of DFP. In preliminary experiments, we observed that DFP treatment of PMN interfered with calcein labeling. Therefore, an alternate method (51Cr labeling) was used for the experiments involving DFP (see below). 2) Labeling with 51Cr: PMN were incubated with 51Cr (10 µCi/1 × 106 PMN) for 25 min at 37°C followed by 15 min at 21°C and then washed twice (14). Standard linear curves of counts per minute vs. PMN were constructed. Cells (3 × 106) were added to the top chamber of the wells containing epithelial monolayers, and chemotaxis was induced for 2 h by addition of 1 µM fMLP to the bottom chamber. At the termination of experiments, the number of cells in each compartment of the chemotaxis chamber was estimated and expressed as a fraction of the total number of PMN retrieved from all compartments of the chamber. At least 75% of the total added radioactivity was recovered in these experiments. Data are from four separate experiments.
Neutrophil chemotaxis assay.
PMN, isolated as described above, were labeled with 1.5 µM calcein AM
for 20 min at 37°C; 96-well microplate chambers with accompanying
3-µm pore polycarbonate filters (Neuro Probe, Cabin John, MD) were
used for this assay. fMLP (1 × 107 M, the
concentration inducing maximal chemotaxis) was added to the lower
compartment, and 25 µl of a suspension containing 4 × 106 PMN/ml was placed on top of the chamber. After a 1-h
incubation at 37°C, fluorescence of each well was determined by using
a Cytofluor 2300 fluorescent plate reader. The number of PMN that
migrated was quantified by using a standard curve (cell number vs.
fluorescence) constructed separately for each set of experiments. All
assays were done in triplicate, with PMN isolated from at least three separate donors.
Oxidative burst.
The reduction of scopoletin was used to measure oxidant production by
PMN, as previously described in detail (47). In brief, PMN
were incubated in sodium buffer (140 mM NaCl, 4 mM KCl, 10 mM glucose,
10 mM HEPES, 1 mM CaCl, pH = 7.4 at 37°C) containing 10.4 µM
scopoletin, 9.6 U/ml horseradish peroxidase, 4 mM sodium azide, and
either 107 M phorbol 12-myristate 13-acetate
(PMA) or 10
7 M fMLP. When indicated,
-1
antitrypsin (0.5 × 10
6 M) was added to wells. Cells
were incubated at 37°C for 2 h, and reduction in fluorescence of
scopoletin was quantified by use of a fluorescence spectrophotometer.
Standard curves were generated by using known amounts of hydrogen
peroxide for each experiment.
Flow cytometric analysis of F-actin content.
PMN content of F-actin was determined by using the method of Howard and
Meyer (24), as previously described (13). In
brief, cells were stimulated with either 107 M PMA or
10
8 M fMLP. After stimulation, cells were fixed and
permeabilized with a mixture of formalin and lysophosphatidylcholine
and then stained with NBD-phallacidin (Molecular Probes, Eugene, OR).
Cells were examined on a FACscan flow cytometer (Beckton Dickinson, Palo Alto, CA), and values are expressed as relative fluorescence index.
Intracellular calcium.
Intracellular calcium ([Ca2+]i) was measured
by use of fura-2, as previously described (47). In brief,
PMN were incubated with 1.5 µM fura 2-AM (Molecular Probes) at 37°C
for 30 min, washed, resuspended in HBSS, and transferred to a cuvette.
Fluorescence was quantified by using a fluorescence spectrophotometer
(Hitachi F-2000) with an excitation wavelength of 346 nm and an
emission wavelength of 510 nm. After equilibration, 107 M
fMLP were added, and alterations in fluorescence readings were recorded. Calibration was done by using ionomycin and Mn2+.
Data are reported as fold increase above baseline after stimulation with fMLP.
Fixation and immunofluorescence microscopy.
Immunofluorescence studies were used to assess the distribution of
proteins involved in intercellular adhesion. Initial studies using
standard methods of fixation and permeabilization were complicated by
an artifactual loss of immunofluorescence of E-cadherin, ZO-1, and
-catenin (16), as has been described for endothelial
cells (34). We determined that the optimal conditions for
epitope preservation included an initial fixation step with 3%
paraformaldehyde for 30 min, followed by incubation with 88% formic
acid for 2.5 min before permeabilization with 0.02% Triton X-100 for 2 min. This both preserved epitopes in control slides and prevented
postfixation degradation under conditions in which PMN were present
(16). In additional experiments, we determined that
methanol fixation (10 min) was optimal for visualization of the actin
cytoskeleton. Fixation and permeabilization were done at 21°C, and
samples were rinsed three times in PBS between all steps before
blocking with 1% bovine serum albumin in PBS (10 min).
SDS-PAGE and immunoblotting.
For SDS-PAGE of whole cell extracts, filter inserts were excised and
placed directly into boiling lysis buffer (2% SDS, 10% glycerol, 65 mM Tris/HCl, pH 6.8, 50 mM dithiothreitol) (27). For
SDS-PAGE analysis of the supernatant from the apical surface of the
monolayer, samples from the lower chamber of eight wells (total 8 ml)
were pooled, protease inhibitors were added (1 mM PMSF, 0.5 mM
benzamidine, 10 µg/ml aprotinin, and 10 µg/ml leupeptin), and
samples were centrifuged (5 min at 900 rpm). Supernatant was concentrated to 1 ml by using Centriprep (Centrifugal Filter Devices) with a molecular mass exclusion of <10 kDa (Millipore,
Bedford, MA). After electrophoresis, proteins were transferred to
nitrocellulose membranes, blocked with 5% low fat milk in PBS with
0.05% Tween-20, and incubated overnight at 4°C with the relevant
antibodies. The primary antibodies were those used for
immunofluorescence studies with the exceptions of anti-E-cadherin
(Sigma Chemical), anti--catenin (Transduction Laboratories,
Lexington, KY), and cytokeratin 18 (Serotec, Raleigh, NC). After
washing, blots were incubated with horseradish peroxidase-conjugated
anti-mouse or anti-rabbit IgG at 1:5,000 dilution for 1 h at room
temperature and developed by use of an enhanced chemiluminescence
system according to manufacturer's instructions (Amersham Canada,
Oakville, ON). When indicated, blots were reprobed with cytokeratin 18 to correct for small differences in protein loading. Quantitative
densitometric analysis of the blots was done by using commercial image
analysis software (IP Lab Gel), and the intensity of all blots was
within the linear range of the film.
Protease inhibition.
Several strategies were used to inactivate leukocyte proteases. To
inhibit cell-associated proteases, including elastase, PMN were
pretreated either with DFP, a serine protease inhibitor, or DMP-777, a
specific neutrophil elastase inhibitor. Alternately, extracellular
proteases were inactivated by addition of -1-antitrypsin (8 nmol/1 × 106 PMN) to buffer. In experiments conducted
to measure extracellular release of elastase, PMN (10 × 106) were preincubated with protease inhibitors or vehicle
control for the indicated times before stimulation with
10
6 M fMLP in the presence of cytochalasin B (5 µM).
After 1 h, cells were centrifuged, and supernatant was immediately frozen.
Elastase assay. Neutrophil elastase activity was determined on samples from apical supernatant of the epithelial cultures after either maximal stimulation of PMN primary granule release or PMN transepithelial migration. To measure maximal primary granule release, the chromogenic substrate specific to human neutrophil elastase, methoxysuccinyl alanyl alanyl prolyl valyl p-nitroanilide (MeOSAAPVpNA, Sigma Chemical) (7) was used. Purified human neutrophil elastase (Elastin Products, Owensville, MO) was used to establish a standard reference. Samples were diluted 1:10 in 100 mM HEPES, 0.5 M NaCl, and 0.1% Brij 35 at pH 7.5 and reacted with 1 mM MeOSAAPVpNA. The change in absorbance per minute at a wavelength of 410 nm was recorded in a spectrophotometer (model DU7, Beckman Instruments). Sample elastase concentrations were determined by referring to the standard reference curve. To measure elastase activity in supernatant after PMN transepithelial migration, the EnzChek Elastase Assay Kit (Molecular Probes) was used, as per the manufacturer's instructions.
Myeloperoxidase assay. Neutrophil myeloperoxidase activity was determined in thawed samples from supernatant after PMN transepithelial migration. Supernatant was added to assay buffer containing Na2PO4, 0.3% H2O2, and 0.1% o-dianisidine hydrochloride. The H2O2-dependent oxidation of o-dianisidine hydrochloride was used as an index of myeloperoxidase activity. One unit of myeloperoxidase was defined as the amount of myeloperoxidase required to degrade 1 µmol H2O2/min at 25°C. Myeloperoxidase values were compared between samples of equal volume of supernatant.
Statistical analysis. Parametric data were compared by using t-tests for mean values or analysis of variance with correction for multiple comparisons (Scheffé's test) when more than two variables were analyzed.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Neutrophil transmigration and epithelial monolayer disruption.
PMN were induced to transmigrate across monolayers of T84 epithelial
cells in the physiological basolateral-apical direction by a
transepithelial gradient of fMLP, a potent PMN chemoattractant. To
study structural alterations induced by PMN transmigration, we examined
the monolayers microscopically. Single PMN infiltrated the monolayer as
early as 20-30 min (Fig. 1,
B and C), but at later time points (1-2 h),
PMN moved through the monolayer in clusters associated with disruption
of the monolayer (Fig. 1, D and E). The formation
of circular defects (holes) in the monolayer coincided with the
appearance of free epithelial cells in the apical culture media,
indicating that neutrophil transmigration led to epithelial detachment.
By 18 h, the majority of PMN had traversed the epithelial
monolayer and subsequently detached from the apical surface, leaving
multiple circular defects in the monolayer (Fig. 1E). The
epithelial cells remaining attached to the membrane were
physiologically viable as determined by their ability to exclude both
trypan blue and propidium iodide (data not shown), indicating that the
effects of the neutrophils on the epithelium were spatially delimited.
|
|
Leukocyte-derived oxidants are not responsible for alterations in
epithelial apical junctions.
To traverse the epithelial monolayer, PMN must somehow induce
disruption of epithelial attachments either to the substratum or to
other epithelial cells (intercellular junctions). PMN possess a number
of potent antimicrobial systems that could effect these alterations in
the epithelial alterations during transmigration. For example, oxidants
generated by either the NADPH oxidase (O
Neutrophil proteases facilitate transepithelial migration.
In addition to oxidants, leukocytes can release proteases such as
elastase that could mediate proteolytic cleavage of the epithelial
attachments (either cell-cell or cell-substratum) and thus facilitate
transmigration of PMN through the epithelial monolayer. If this concept
is correct, the prediction is that protease inhibitors should interfere
with PMN transmigration across the epithelium. This possibility was
investigated by using several chemically distinct protease inhibitors.
The high molecular weight protease inhibitor -1-antitrypsin was used
to inhibit proteases released into the extracellular space.
Alternately, PMN were pretreated with one of two cell-permeant protease
inhibitors, DFP (an irreversible serine protease inhibitor; Refs.
28, 30) or DMP-777 (a specific elastase
inhibitor; Refs. 9, 35, 46).
Pretreatment of cells with either DFP or DMP-777 would be expected to
neutralize proteases such as elastase contained within neutrophil
granules and thus completely abrogate their effects during
transmigration. To ensure that the agents used actually inhibited PMN
elastase under the conditions of our experiments, we quantified
elastase activity after maximal stimulation of PMN azurophilic granule
release. Incubation of PMN with
-1-antitrypsin resulted in partial
inhibition whereas pretreatment of PMN with either DFP or DMP-777
resulted in complete inhibition of extracellular elastase activity
(Table 1).
|
|
|
|
Neutrophil transmigration is associated with alterations in the epithelial junctional complex. Our studies suggested that PMN transmigration resulted in disruption of the epithelial monolayer with detachment and loss of epithelial cells. To examine the morphological alterations in the monolayer that resulted from PMN transmigration in more detail, we utilized confocal immunofluorescence microscopy. In agreement with transmitted light microscopic studies, focal areas of epithelial disruption were observed by immunofluorescence microscopy using rhodamine phalloidin to label the actin cytoskeleton of epithelial cells and anti-CD15 to label the PMN (data not shown).
Focal loss of immunofluorescence staining of junctional proteins was observed during PMN transmigration through the monolayer. In particular, the adherens junction proteins E-cadherin and
|
Late alterations in apical junctional proteins.
Recent studies have suggested that apical junction proteins modulate
epithelial migration and monolayer formation during repair of
epithelial wounds (1). We endeavored to characterize
alterations in epithelial apical junctional proteins that occurred
subsequent to PMN infiltration. Our goal was to determine whether the
loss and/or redistribution of these proteins observed during the early phases of PMN infiltration persisted at later time points and during
repair of the epithelium. To define the distribution of intercellular
proteins at the sites of epithelial loss (microinjury), we studied
epithelial intercellular junctions 18 and 30 h after the addition
of PMN. After fixation, double labeling with rhodamine phalloidin to
visualize the actin cytoskeleton of the epithelium (data not shown) and
antibodies to either E-cadherin or -catenin to visualize the
junctional proteins revealed circular defects in the epithelium
associated with focal loss of E-cadherin (Fig. 4G) and
-catenin immunofluorescence (data not shown). To evaluate relative
alterations in adherens junction and tight junction protein distribution, double-label immunofluorescence with combinations of
either anti-E-cadherin and anti-ZO-1 or anti-
-catenin and anti-ZO-1
antibodies was utilized. These studies revealed that E-cadherin (Fig.
4G) and
-catenin (not shown) immunofluorescence signals
were decreased at the epithelial cell membrane bordering these regions,
whereas staining of ZO-1, a tight junction protein well localized to
the apical epithelial surface, was relatively preserved (Fig. 4,
H and I).
|
Evidence of limited proteolytic degradation of adherens junction
proteins.
To determine the contribution of proteolytic degradation to the loss of
adherens junction protein immunofluorescence staining at sites of
microinjury, we initially utilized immunoblotting to quantify the
amount of adherens junction and other proteins in the epithelial
monolayers. Cells from the entire filter insert were lysed directly in
identical volumes of denaturing lysis buffer and subjected to SDS-PAGE
and immunoblot analysis. E-cadherin and -catenin levels were
normalized to that of cytokeratin 18 (Fig.
6A, top). No significant
change in E-cadherin (88 ± 11%) or
-catenin levels (101 ± 9%) after 2 h of induced PMN transmigration was observed.
Thus, within the limits of sensitivity of Western blotting, degradation
of adherens junction proteins at 2 h after induced PMN
transmigration could not be detected. Similarly, no decrease in the
tight junction protein, ZO-1, was observed (data not shown).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PMN transmigration across epithelium in many inflammatory conditions is associated with injury to and dysfunction of the epithelial barrier. Our data demonstrate that PMN transmigration leads to loss of epithelial cells from the monolayer, creating defects (areas of microinjury) that are spatially associated with clustered PMN and a localized disruption of E-cadherin. Release of proteolytic fragments of E-cadherin into the supernatant occurred during transmigration and was prevented by elastase inhibitors, consistent with spatially delimited degradation of this adherens junction protein by leukocyte-derived proteases. The notion that leukocyte-derived elastase is important in the pathogenesis of epithelial injury in inflammatory bowel disease is supported by animal models of colitis in which the administration of anti-elastase compounds ameliorates intestinal damage (36) and by reports that levels of elastase are elevated in the gut lumen of patients with inflammatory bowel disease (2, 19).
After the initial phase of PMN transmigration, during which individual ("scout") PMN passed between epithelial cells, PMN did not advance randomly but rather traversed the monolayer in clusters associated with areas of epithelial loss. Sites in the monolayer through which the initial PMN pass may represent areas of weakness in intercellular junctions. Passage of scout PMN through these areas might further promote additional PMN transmigration by several mechanisms, such as disruption of intercellular junctions resulting in microdomains of an increased chemotactic gradient. Quantitative analysis supported the concept that PMN traversed the monolayer primarily in groups and migrated preferentially through areas of epithelial loss. Specifically, doubling the number of PMN added to the basal surface resulted in a threefold increase in the number of PMN that completely transmigrated the monolayer, whereas the loss of epithelial surface area only increased by a factor of 1.7. Thus, when increased numbers PMN were added to the basal epithelial surface, relatively more PMN transmigrated per unit of epithelial surface area lost (9.54 × 103 vs. 18.6 × 103 PMN transmigrated/mm2 of surface area lost, respectively).
Disrupted E-cadherin staining at sites of PMN infiltration could be accounted for by several different mechanisms. PMN may physically displace epithelial junctional proteins. Alternatively, the junctional proteins may redistribute away from the site of PMN infiltration, either remaining on the cell surface or becoming internalized. In the present study, we provide evidence for a third possibility, specifically that there is limited proteolytic degradation of E-cadherin mediated by neutrophil elastase.
It is noteworthy that we observed a diminution of E-cadherin immunofluorescence at the periphery of migrating epithelial cells during the later phase of repair of the monolayer. Although morphologically similar, the changes in the epithelial apical junctional proteins during the initial phase of PMN transmigration and later during monolayer repair may be mechanistically distinct. Various mechanisms have been proposed that facilitate epithelial wound closure in other model systems. Early experiments conducted with adult epidermal epithelial cells demonstrated that lamellipodia extend into wounds during epithelial repair (32). In embryonic epidermis, an actin cable was visualized at the edge of wounds and postulated to act as a contractile "purse string" during wound closure (32). Similarly, experiments using cell lines suggest that both lamellipodial extension and formation of actin filament rings (5, 39) occur during epithelial repair processes.
The potential role of E-cadherin in epithelial cell migration is
complex. Reduction in adherens junction proteins has been reported in
vivo at the site of inflammatory cell infiltration in disease states
associated with epithelial ulceration (11, 18, 45).
Studies of mouse small intestinal epithelium in which E-cadherin or
-catenin was overexpressed demonstrated a slowing of normal cell
migration from the crypt to the villus (23, 48), indicating that the formation of adherens junctions may correlate with
decreased cell migratory ability. In the present study, we observed a
decrease in E-cadherin at the periphery of sites of epithelial
denudation, consistent with the concept that redistribution of these
proteins away from the leading edge of cells facilitates epithelial
migration into the wound.
Our observations suggest that there is limited proteolytic degradation of junctional proteins by neutrophil elastase during PMN transmigration. Exogenous elastase-mediated degradation of the E-cadherin seems to require access of the protease to the basolateral interepithelial space (as evidenced by the requirement of EDTA to open tight junctions). PMN encounter the apical junctional complex during their basolateral to apical migration across epithelium. Local release of PMN proteases may disrupt the junctional complexes by spatially delimited proteolytic degradation mediated in part by leukocyte elastase or other PMN-derived proteases. Alternatively, the effects of PMN elastase could be indirect; elastase could induce changes in epithelial cells leading to activation of alternate proteolytic systems (perhaps epithelium derived) that are the proximate mediators of adherens junction protein degradation. Our experimental system does not allow us to distinguish unequivocally between these possibilities.
Recent investigations of alterations in endothelial -catenin after
PMN adhesion have yielded conflicting results (3, 10, 34).
Similar to Moll et al. (34), our laboratory
(16) observed that PMN-derived products, likely
proteases released after permeabilization, remain active despite
exposure to fixatives and may be responsible for an artifactual diffuse
degradation of adherens junction proteins. These proteases are
resistant to many commonly utilized protease inhibitors (3, 10,
34). By analogy, human or animal tissues fixed by conventional
methods that contain infiltrating PMN may well exhibit similar
(artifactual) protein degradation. This may complicate the
interpretation of reports of loss of adherens junction proteins in
conditions in which PMN are present in the tissue, such as inflammatory
bowel diseases (11, 18, 45).
In summary, PMN transepithelial migration leads to disruption of the epithelial adherens junctions and detachment of epithelial cells from the monolayer. This is associated with spatially delimited proteolytic degradation of E-cadherin by neutrophil elastase. These data provide a model for the pathogenesis of epithelial ulcerations observed in inflammatory bowel disease, highlight the importance of leukocyte elastase in these processes, and may provide direction for the development of rational therapeutic interventions to ameliorate or prevent this inflammatory epithelial injury.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Dr. Alan Burns (Baylor College of Medicine) for helpful discussions regarding fixation techniques and Drs. C. Bear and S. Grinstein for helpful discussions.
![]() |
FOOTNOTES |
---|
This work was supported by operating grants from the Ontario Thoracic Society, the Medical Research Council of Canada, the National Institutes of Health, and the American Digestive Health Foundation (Martin Brotman Award). H. Ginzberg is a recipient of a Research Fellowship from the Canadian Crohn's and Colitis Foundation and the Canadian Association of Gastroenterology/Astra Zeneca Research Initiative Award. G. Downey holds the R. Fraser Elliott Chair in Transplantation Research from the Toronto General Hospital of the University Health Network and is the recipient of a Canada Research Chair in respiration.
Address for reprint requests and other correspondence: G. P. Downey, Clinical Sciences, Rm. 6264 Medical Sciences Bldg., Univ. of Toronto, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8 (E-mail: gregory.downey{at}utoronto.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 14 November 2000; accepted in final form 24 April 2001.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Adams, CL,
Chen YT,
Smith SJ,
and
Nelson WJ.
Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-green fluorescent protein.
J Cell Biol
142:
1105-1119,
1998
2.
Adeyemi, EO,
and
Hodgson HJ.
Faecal elastase reflects disease activity in active ulcerative colitis.
Scand J Gastroenterol
27:
139-142,
1992[ISI][Medline].
3.
Allport, JR,
Ding H,
Collins T,
Gerritsen ME,
and
Luscinskas FW.
Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions.
J Exp Med
186:
517-527,
1997
4.
Bachofen, M,
and
Weibel ER.
Basic pattern of tissue repair in human lungs following unspecific injury.
Chest, Suppl
65:
14S-19S,
1974.
5.
Bement, WM,
Forscher P,
and
Mooseker MS.
A novel cytoskeletal structure involved in purse string wound closure and cell polarity maintenance.
J Cell Biol
121:
565-578,
1993[Abstract].
6.
Cantin, AM,
Lafrenaye S,
and
Begin RO.
Antineutrophil elastase activity in cystic fibrosis serum.
Pediatr Pulmonol
11:
249-253,
1991[ISI][Medline].
7.
Castillo, MJ,
Nakajima K,
Zimmerman M,
and
Powers JC.
Sensitive substrates for human leukocyte and porcine pancreatic elastase: a study of the merits of various chromophoric and fluorogenic leaving groups in assays for serine proteases.
Anal Biochem
99:
53-64,
1979[ISI][Medline].
8.
Champagne, B,
Tremblay P,
Cantin A,
and
St. Pierre Y.
Proteolytic cleavage of ICAM-1 by human neutrophil elastase.
J Immunol
161:
6398-6405,
1998
9.
Cvetovich, RJ,
Chartrain M,
Hartner FW,
Roberge C,
Amato JS,
and
Grabowski EJJ
An asymmetric synthesis of L-694,458, a human leukocyte elastase inhibitor, via novel enzyme resolution of -lactam esters.
J Org Chem
61:
6575-6580,
1996[ISI][Medline].
10.
Del Maschio, A,
Zanetti A,
Corada M,
Rival Y,
Ruco L,
Lampugnani MG,
and
Dejana E.
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions.
J Cell Biol
135:
497-510,
1996[Abstract].
11.
Dogan, A,
Wang ZD,
and
Spencer J.
E-cadherin expression in intestinal epithelium.
J Clin Pathol
48:
143-146,
1995[Abstract].
12.
Downey, GP,
Chan CK,
Lea P,
Takai A,
and
Grinstein S.
Phorbol ester-induced actin assembly in neutrophils: role of protein kinase C.
J Cell Biol
116:
695-706,
1992[Abstract].
13.
Downey, GP,
Chan CK,
Trudel S,
and
Grinstein S.
Actin assembly in electropermeabilized neutrophils: role of intracellular calcium.
J Cell Biol
110:
1975-1982,
1990[Abstract].
14.
Gallin, JI,
Clark RA,
and
Kimball HR.
Granulocyte chemotaxis: an improved in vitro assay employing 51Cr-labeled granulocytes.
J Immunol
110:
233-240,
1973[ISI][Medline].
15.
Geiger, B,
and
Ayalon O.
Cadherins.
Annu Rev Cell Biol
8:
307-332,
1992[ISI].
16.
Ginzberg, H,
Shannon P,
and
Downey GP.
Neutrophil products and alterations in epithelial junctional proteins: prevention of artifactual degradation.
J Immunol Methods
239:
45-52,
2000[ISI][Medline].
17.
Hampton, MB,
and
Winterbourn CC.
Modification of neutrophil oxidant production with diphenyleneiodonium and its effect on bacterial killing.
Free Radic Biol Med
18:
633-639,
1995[ISI][Medline].
18.
Hanby, AM,
Chinery R,
Poulsom R,
Playford RJ,
and
Pignatelli M.
Downregulation of E-cadherin in the reparative epithelium of the human gastrointestinal tract.
Am J Pathol
148:
723-729,
1996[Abstract].
19.
Handy, LM,
Ghosh S,
and
Ferguson A.
Investigation of neutrophils in the gut lumen by assay of granulocyte elastase in whole-gut lavage fluid.
Scand J Gastroenterol
31:
700-705,
1996[ISI][Medline].
20.
Haslett, C,
Guthrie LA,
Kopaniak MM,
Johnston RB, Jr,
and
Henson PM.
Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide.
Am J Pathol
119:
101-110,
1985[Abstract].
21.
Heinzelmann, M,
Mercer-Jones MA,
and
Passmore JC.
Neutrophils and renal failure.
Am J Kidney Dis
34:
384-399,
1999[ISI][Medline].
22.
Hermiston, ML,
and
Gordon JI.
Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin.
Science
270:
1203-1207,
1995[Abstract].
23.
Hermiston, ML,
Wong MH,
and
Gordon JI.
Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system.
Genes Dev
10:
985-996,
1996[Abstract].
24.
Howard, TH,
and
Meyer WH.
Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.
J Cell Biol
98:
1265-1271,
1984[Abstract].
25.
Jaeschke, H,
Smith CW,
Clemens MG,
Ganey PE,
and
Roth RA.
Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils.
Toxicol Appl Pharmacol
139:
213-226,
1996[ISI][Medline].
26.
Kondo, M,
Finkbeiner WE,
and
Widdicombe JH.
Changes in permeability of dog tracheal epithelium in response to hydrostatic pressure.
Am J Physiol Lung Cell Mol Physiol
262:
L176-L182,
1992
27.
Laemmli, UK.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:
680-685,
1970[ISI][Medline].
28.
Laskowski, M, Jr.
Protein inhibitors of serine proteinasesmechanism and classification.
Adv Exp Med Biol
199:
1-17,
1986[Medline].
29.
Liu, L,
Mul FPJ,
Lutter R,
Roos D,
and
Knol EF.
Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction.
Am J Respir Cell Mol Biol
15:
771-780,
1996[Abstract].
30.
Lundqvist, H,
and
Dahlgren C.
The serine protease inhibitor diisopropylfluorophosphate inhibits neutrophil NADPH-oxidase activity induced by the calcium ionophore ionomycin and serum opsonised yeast particles.
Inflamm Res
44:
510-517,
1995[ISI][Medline].
31.
MacMicking, J,
Xie QW,
and
Nathan C.
Nitric oxide and macrophage function.
Annu Rev Immunol
15:
323-350,
1997[ISI][Medline].
32.
Martin, P,
and
Lewis J.
Actin cables and epidermal movement in embryonic wound healing.
Nature
360:
179-183,
1992[ISI][Medline].
33.
Molitoris, BA.
New insights into the cell biology of ischemic acute renal failure.
J Am Soc Nephrol
1:
1263-1270,
1991[Abstract].
34.
Moll, T,
Dejana E,
and
Vestweber D.
In vitro degradation of endothelial catenins by a neutrophil protease.
J Cell Biol
140:
403-407,
1998
35.
Mumford, R,
Chabin S,
Chiu S,
Davies P,
Doherty J,
Finke P,
Fletcher D,
Green B,
Griffin P,
Kissinger A,
Knight W,
Kostura M,
Klatt T,
MacCoss M,
Meurer R,
Miller D,
Pacholok S,
Poe M,
Shah S,
Vincent S,
Williams H,
and
Humes J.
A cell-penetrant monocyclic -lactam inhibitor (MBI) which inactivates elastase (E) within PMN in vitro and in vivo (Abstract).
Respir Crit Care Med
151:
A532,
1995.
36.
Nagao, Y,
Miyata H,
Mizuguchi K,
Ban M,
and
Kato K.
[Effects of ulinastatin on experimental ulcerative colitis in rats].
Nippon Yakurigaku Zasshi
109:
41-52,
1997[Medline].
37.
Nash, S,
Stafford J,
and
Madara JL.
Effects of polymorphonuclear leukocyte transmigration on the barrier function of cultured intestinal epithelial monolayers.
J Clin Invest
80:
1104-1113,
1987[ISI][Medline].
38.
Nash, S,
Stafford J,
and
Madara JL.
The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration.
Lab Invest
59:
531-537,
1988[ISI][Medline].
39.
Nusrat, A,
Parkos CA,
Liang TW,
Carnes DK,
and
Madara JL.
Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair.
Gastroenterology
113:
1489-1500,
1997[ISI][Medline].
40.
O'Donnell, BV,
Tew DG,
Jones OT,
and
England PJ.
Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase.
Biochem J
290:
41-49,
1993[ISI][Medline].
41.
Panes, J,
and
Granger DN.
Leukocyte-endothelial cell interactions: implications for the pathogenesis and treatment of gastrointestinal disease.
Dig Dis
12:
232-241,
1994[ISI][Medline].
42.
Parkos, CA,
Delp C,
Arnaout MA,
and
Madara JL.
Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction.
J Clin Invest
88:
1605-1612,
1991[ISI][Medline].
43.
Stevenson, BR,
Siliciano JD,
Mooseker MS,
and
Goodenough DA.
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia.
J Cell Biol
103:
755-766,
1986[Abstract].
44.
Trudel, S,
Paquet MR,
and
Grinstein S.
Mechanism of vanadate-induced activation of tyrosine phosphorylation and of the respiratory burst in HL60 cells. Role of reduced oxygen metabolites.
Biochem J
276:
611-619,
1991[ISI][Medline].
45.
Valizadeh, A,
Karayiannakis AJ,
el-Hariry I,
Kmiot W,
and
Pignatelli M.
Expression of E-cadherin-associated molecules (-,
-, and
-catenins and p120) in colorectal polyps.
Am J Pathol
150:
1977-1984,
1997[Abstract].
46.
Vincent, SH,
Painter SK,
Luffer-Atlas D,
Karanam BV,
McGowan E,
Cioffe C,
Doss G,
and
Chiu SH.
Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
Drug Metab Dispos
25:
932-939,
1997
47.
Waddell, TK,
Fialkow L,
Chan CK,
Kishimoto TK,
and
Downey GP.
Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin.
J Biol Chem
269:
18485-18491,
1994
48.
Wong, MH,
Rubinfeld B,
and
Gordon JI.
Effects of forced expression of an NH2-terminal truncated -catenin on mouse intestinal epithelial homeostasis.
J Cell Biol
141:
765-777,
1998